-
1
-
-
77951648520
-
Proteomics in Parkinson's disease: Current trends, translational snags and future possibilities
-
G. Srivastava, K. Singh, M. N. Tiwari, and M. P. Singh, Proteomics in Parkinson's disease: Current trends, translational snags and future possibilities. Expert Rev. Proteomics 7, 127 (2010).
-
(2010)
Expert Rev. Proteomics
, vol.7
, pp. 127
-
-
Srivastava, G.1
Singh, K.2
Tiwari, M.N.3
Singh, M.P.4
-
2
-
-
33749184503
-
Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease
-
M. P. Singh, S. Patel, M. Dikshit, and Y. K. Gupta, Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease. Indian J. Biochem. Biophys. 43, 69 (2006).
-
(2006)
Indian J. Biochem. Biophys.
, vol.43
, pp. 69
-
-
Singh, M.P.1
Patel, S.2
Dikshit, M.3
Gupta, Y.K.4
-
3
-
-
84856721686
-
Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: Is it all set to irrefutable clinical translation
-
N. K. Singhal, G. Srivastava, S. Agrawal, S. K. Jain, and M. P. Singh, Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: Is it all set to irrefutable clinical translation. Mol. Neurobiol. 45, 186 (2012).
-
(2012)
Mol. Neurobiol.
, vol.45
, pp. 186
-
-
Singhal, N.K.1
Srivastava, G.2
Agrawal, S.3
Jain, S.K.4
Singh, M.P.5
-
4
-
-
0141741347
-
Parkinson's disease: Mechanisms and models
-
W. Dauer and S. Przedborski, Parkinson's disease: Mechanisms and models. Neuron 39, 889 (2003).
-
(2003)
Neuron
, vol.39
, pp. 889
-
-
Dauer, W.1
Przedborski, S.2
-
5
-
-
84877328104
-
Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease
-
A. Dixit, G. Srivastava, D. Verma, M. Mishra, P. K. Singh, O. Prakash, and M. P. Singh, Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease. Biochim. Biophys. Acta Mol. Basis Dis. 1832, 1227 (2013).
-
(2013)
Biochim. Biophys. Acta Mol. Basis Dis.
, vol.1832
, pp. 1227
-
-
Dixit, A.1
Srivastava, G.2
Verma, D.3
Mishra, M.4
Singh, P.K.5
Prakash, O.6
Singh, M.P.7
-
6
-
-
84894369187
-
Does restraining nitric oxide biosynthesis rescue from toxins-induced Parkinsonism and sporadic Parkinson's disease
-
S. P. Gupta, S. Yadav, N. K. Singhal, M. N. Tiwari, S. K. Mishra, and M. P. Singh, Does restraining nitric oxide biosynthesis rescue from toxins-induced Parkinsonism and sporadic Parkinson's disease. Mol. Neurobiol. 49, 262 (2014).
-
(2014)
Mol. Neurobiol.
, vol.49
, pp. 262
-
-
Gupta, S.P.1
Yadav, S.2
Singhal, N.K.3
Tiwari, M.N.4
Mishra, S.K.5
Singh, M.P.6
-
7
-
-
84894202546
-
Role of nitric oxide in the regulation of motor function. An overview of behavioral, biochemical and histological studies in animal models
-
E. Lorenc-Koci and A. Czarnecka, Role of nitric oxide in the regulation of motor function. An overview of behavioral, biochemical and histological studies in animal models. Pharmacol. Rep. 65, 1043 (2013).
-
(2013)
Pharmacol. Rep.
, vol.65
, pp. 1043
-
-
Lorenc-Koci, E.1
Czarnecka, A.2
-
8
-
-
77956209909
-
Effects of caffeine in Parkinson's disease: From neuroprotection to the management of motor and non-motor symptoms
-
R. D. Prediger, Effects of caffeine in Parkinson's disease: From neuroprotection to the management of motor and non-motor symptoms. J. Alzheimers Dis. 20, S205 (2010).
-
(2010)
J. Alzheimers Dis.
, vol.20
, pp. S205
-
-
Prediger, R.D.1
-
9
-
-
77956180419
-
Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases
-
X. Chen, O. Ghribi, and J. D. Geiger, Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J. Alzheimers Dis. 20, S127 (2010).
-
(2010)
J. Alzheimers Dis.
, vol.20
, pp. S127
-
-
Chen, X.1
Ghribi, O.2
Geiger, J.D.3
-
10
-
-
0035690443
-
Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease
-
G. W. Ross and H. Petrovitch, Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease. Drugs Aging 18, 797 (2001).
-
(2001)
Drugs Aging
, vol.18
, pp. 797
-
-
Ross, G.W.1
Petrovitch, H.2
-
11
-
-
0028289758
-
The effect of theophylline on parkinsonian symptoms
-
J. Mally and T. Stone, The effect of theophylline on parkinsonian symptoms. J. Pharm. Pharmacol. 46, 515 (1994).
-
(1994)
J. Pharm. Pharmacol.
, vol.46
, pp. 515
-
-
Mally, J.1
Stone, T.2
-
12
-
-
52949091483
-
Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels
-
S. Guerreiro, D. Toulorge, E. Hirsch, M. Marien, P. Sokoloff, and P. P. Michel, Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Mol. Pharmacol. 74, 980 (2008).
-
(2008)
Mol. Pharmacol.
, vol.74
, pp. 980
-
-
Guerreiro, S.1
Toulorge, D.2
Hirsch, E.3
Marien, M.4
Sokoloff, P.5
Michel, P.P.6
-
13
-
-
77954541590
-
Caffeine attenuates lipopolysaccharide-induced neuroinflammation
-
H. M. Brothers, Y. Marchalant, and G. L. Wenk, Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neurosci. Lett. 480, 97 (2010).
-
(2010)
Neurosci. Lett.
, vol.480
, pp. 97
-
-
Brothers, H.M.1
Marchalant, Y.2
Wenk, G.L.3
-
14
-
-
84862876684
-
Role of secondary mediators in caffeine-mediated neuroprotection in maneb-and paraquat-induced Parkinson's disease phenotype in the mouse
-
S. Yadav, S. P. Gupta, G. Srivastava, P. K. Srivastava, and M. P. Singh, Role of secondary mediators in caffeine-mediated neuroprotection in maneb-and paraquat-induced Parkinson's disease phenotype in the mouse. Neurochem. Res. 37, 875 (2012).
-
(2012)
Neurochem. Res.
, vol.37
, pp. 875
-
-
Yadav, S.1
Gupta, S.P.2
Srivastava, G.3
Srivastava, P.K.4
Singh, M.P.5
-
15
-
-
41949099544
-
Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse
-
S. Singh, K. Singh, S. Patel, D. K. Patel, C. Singh, C. Nath, and M. P. Singh, Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse. Brain Res. 1207, 193 (2008).
-
(2008)
Brain Res.
, vol.1207
, pp. 193
-
-
Singh, S.1
Singh, K.2
Patel, S.3
Patel, D.K.4
Singh, C.5
Nath, C.6
Singh, M.P.7
-
16
-
-
77952011682
-
Nicotine-and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism
-
K. Singh, S. Singh, N. K. Singhal, A. Sharma, D. Parmar, and M. P. Singh, Nicotine-and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism. Chem. Biol. Interact. 185, 81 (2010).
-
(2010)
Chem. Biol. Interact.
, vol.185
, pp. 81
-
-
Singh, K.1
Singh, S.2
Singhal, N.K.3
Sharma, A.4
Parmar, D.5
Singh, M.P.6
-
17
-
-
84883192944
-
Nicotine-encapsulated poly(lacticco-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism
-
M. N. Tiwari, S. Agarwal, P. Bhatnagar, N. K. Singhal, S. K. Tiwari, P. Kumar, L. K. Chauhan, D. K. Patel, R. K. Chaturvedi, M. P. Singh, and K. C. Gupta, Nicotine-encapsulated poly(lacticco-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism. Free Radic. Biol. Med. 65, 704 (2013).
-
(2013)
Free Radic. Biol. Med.
, vol.65
, pp. 704
-
-
Tiwari, M.N.1
Agarwal, S.2
Bhatnagar, P.3
Singhal, N.K.4
Tiwari, S.K.5
Kumar, P.6
Chauhan, L.K.7
Patel, D.K.8
Chaturvedi, R.K.9
Singh, M.P.10
Gupta, K.C.11
-
18
-
-
0345227300
-
Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration
-
C. A. Tobias, J. S. Shumsky, M. Shibata, M. H. Tuszynski, I. Fischer, A. Tessler, and M. Murray, Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp. Neurol. 184, 97 (2003).
-
(2003)
Exp. Neurol.
, vol.184
, pp. 97
-
-
Tobias, C.A.1
Shumsky, J.S.2
Shibata, M.3
Tuszynski, M.H.4
Fischer, I.5
Tessler, A.6
Murray, M.7
-
19
-
-
68149160611
-
Nanoparticle-mediated delivery of superoxide dismutase to the brain: An effective strategy to reduce ischemia-reperfusion injury
-
M. K. Reddy and V. Labhasetwar, Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J. 23, 1384 (2009).
-
(2009)
FASEB J.
, vol.23
, pp. 1384
-
-
Reddy, M.K.1
Labhasetwar, V.2
-
20
-
-
80051788387
-
Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration
-
Y. M. Tsai, C. F. Chien, L. C. Lin, and T. H. Tsai, Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration. Int. J. Pharm. 416, 331 (2011).
-
(2011)
Int. J. Pharm.
, vol.416
, pp. 331
-
-
Tsai, Y.M.1
Chien, C.F.2
Lin, L.C.3
Tsai, T.H.4
-
21
-
-
77951773926
-
Brain-targeted delivery of Tempolloaded nanoparticles for neurological disorders
-
R. T. Carroll, D. Bhatia, W. Geldenhuys, R. Bhatia, N. Miladore, A. Bishayee, and V. Sutariya, Brain-targeted delivery of Tempolloaded nanoparticles for neurological disorders. J. Drug Target. 18, 665 (2010).
-
(2010)
J. Drug Target.
, vol.18
, pp. 665
-
-
Carroll, R.T.1
Bhatia, D.2
Geldenhuys, W.3
Bhatia, R.4
Miladore, N.5
Bishayee, A.6
Sutariya, V.7
-
22
-
-
84864506840
-
Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease
-
R. K. Chaturvedi, T. Hennessey, A. Johri, S. K. Tiwari, D. Mishra, S. Agarwal, Y. S. Kim, and M. F. Beal, Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease. Hum. Mol. Genet. 21, 3474 (2012).
-
(2012)
Hum. Mol. Genet.
, vol.21
, pp. 3474
-
-
Chaturvedi, R.K.1
Hennessey, T.2
Johri, A.3
Tiwari, S.K.4
Mishra, D.5
Agarwal, S.6
Kim, Y.S.7
Beal, M.F.8
-
23
-
-
54349106751
-
Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum
-
X. Chen, X. Lan, I. Roche, R. Liu, and J. D. Geiger, Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J. Neurochem. 107, 1147 (2008).
-
(2008)
J. Neurochem.
, vol.107
, pp. 1147
-
-
Chen, X.1
Lan, X.2
Roche, I.3
Liu, R.4
Geiger, J.D.5
-
24
-
-
82755192147
-
Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: Postnatal exposure enhances the susceptibility during adulthood
-
A. K. Singh, M. N. Tiwari, G. Upadhyay, D. K. Patel, D. Singh, O. Prakash, and M. P. Singh, Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol. Aging 33, 404 (2012).
-
(2012)
Neurobiol. Aging
, vol.33
, pp. 404
-
-
Singh, A.K.1
Tiwari, M.N.2
Upadhyay, G.3
Patel, D.K.4
Singh, D.5
Prakash, O.6
Singh, M.P.7
-
25
-
-
0036341564
-
HPLC Method for the analysis of paracetamol, caffeine and dipyrone
-
M. L. Altun, HPLC Method for the analysis of paracetamol, caffeine and dipyrone. Turk. J. Chem. 26, 521 (2002).
-
(2002)
Turk. J. Chem.
, vol.26
, pp. 521
-
-
Altun, M.L.1
-
26
-
-
84857932521
-
Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb-and paraquat-induced Parkinsonism in the mouse
-
G. Srivastava, A. Dixit, S. Yadav, D. K. Patel, O. Prakash, and M. P. Singh, Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb-and paraquat-induced Parkinsonism in the mouse. Free Radic. Biol. Med. 52, 1294 (2012).
-
(2012)
Free Radic. Biol. Med.
, vol.52
, pp. 1294
-
-
Srivastava, G.1
Dixit, A.2
Yadav, S.3
Patel, D.K.4
Prakash, O.5
Singh, M.P.6
-
27
-
-
77955550457
-
Involvement of nitric oxide in maneb-and paraquat-induced Parkinson's disease phenotype in mouse: Is there any link with lipid peroxidation
-
S. P. Gupta, S. Patel, S. Yadav, A. K. Singh, S. Singh, and M. P. Singh, Involvement of nitric oxide in maneb-and paraquat-induced Parkinson's disease phenotype in mouse: Is there any link with lipid peroxidation. Neurochem. Res. 35, 1206 (2010).
-
(2010)
Neurochem. Res.
, vol.35
, pp. 1206
-
-
Gupta, S.P.1
Patel, S.2
Yadav, S.3
Singh, A.K.4
Singh, S.5
Singh, M.P.6
-
28
-
-
79951575703
-
Enhancement of neurite outgrowth in PC12 cells by iron oxide nanoparticles
-
J. A. Kim, N. Lee, B. H. Kim, W. J. Rhee, S. Yoon, T. Hyeon, and T. H. Park, Enhancement of neurite outgrowth in PC12 cells by iron oxide nanoparticles. Biomaterials 32, 2871 (2011).
-
(2011)
Biomaterials
, vol.32
, pp. 2871
-
-
Kim, J.A.1
Lee, N.2
Kim, B.H.3
Rhee, W.J.4
Yoon, S.5
Hyeon, T.6
Park, T.H.7
-
29
-
-
84868349443
-
Control of cell adhesion and neurite outgrowth by patterned gold nanoparticles with tunable attractive or repulsive surface properties
-
S. Gilles, S. Winter, K. E. Michael, S. H. Meffert, P. Li, K. Greben, U. Simon, A. Offenhausser, and D. Mayer, Control of cell adhesion and neurite outgrowth by patterned gold nanoparticles with tunable attractive or repulsive surface properties. Small 8, 3357 (2012).
-
(2012)
Small
, vol.8
, pp. 3357
-
-
Gilles, S.1
Winter, S.2
Michael, K.E.3
Meffert, S.H.4
Li, P.5
Greben, K.6
Simon, U.7
Offenhausser, A.8
Mayer, D.9
-
30
-
-
84873157042
-
Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease
-
K. W. Lee, J. Y. Im, J. M. Woo, H. Grosso, Y. S. Kim, A. C. Cristovao, P. K. Sonsalla, D. S. Schuster, M. M. Jalbut, J. R. Fernandez, M. Voronkov, E. Junn, S. P. Braithwaite, J. B. Stock, and M. M. Mouradian, Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease. Neurotherapeutics 10, 143 (2013).
-
(2013)
Neurotherapeutics
, vol.10
, pp. 143
-
-
Lee, K.W.1
Im, J.Y.2
Woo, J.M.3
Grosso, H.4
Kim, Y.S.5
Cristovao, A.C.6
Sonsalla, P.K.7
Schuster, D.S.8
Jalbut, M.M.9
Fernandez, J.R.10
Voronkov, M.11
Junn, E.12
Braithwaite, S.P.13
Stock, J.B.14
Mouradian, M.M.15
-
31
-
-
84866872520
-
Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-B activation and ERK phosphorylation
-
C. H. Kang, R. G. Jayasooriya, M. G. Dilshara, Y. H. Choi, Y. K. Jeong, N. D. Kim, and G. Y. Kim, Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-B activation and ERK phosphorylation. Food Chem. Toxicol. 50, 4270 (2012).
-
(2012)
Food Chem. Toxicol.
, vol.50
, pp. 4270
-
-
Kang, C.H.1
Jayasooriya, R.G.2
Dilshara, M.G.3
Choi, Y.H.4
Jeong, Y.K.5
Kim, N.D.6
Kim, G.Y.7
-
32
-
-
39149085654
-
Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells
-
K. Nakaso, S. Ito, and K. Nakashima, Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci. Lett. 432, 146 (2008).
-
(2008)
Neurosci. Lett.
, vol.432
, pp. 146
-
-
Nakaso, K.1
Ito, S.2
Nakashima, K.3
-
33
-
-
0025988085
-
MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease
-
M. Gerlach, P. Riederer, H. Przuntek, and M. B. Youdim, MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur. J. Pharmacol. 208, 273 (1991).
-
(1991)
Eur. J. Pharmacol.
, vol.208
, pp. 273
-
-
Gerlach, M.1
Riederer, P.2
Przuntek, H.3
Youdim, M.B.4
-
34
-
-
77950867025
-
Neuroprotection by caffeine: Time course and role of its metabolites in the MPTP model of Parkinson's disease
-
K. Xu, Y. H. Xu, J. F. Chen, and M. A. Schwarzschild, Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease. Neuroscience 167, 475 (2010).
-
(2010)
Neuroscience
, vol.167
, pp. 475
-
-
Xu, K.1
Xu, Y.H.2
Chen, J.F.3
Schwarzschild, M.A.4
-
35
-
-
0037713489
-
The 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model: A tool to explore the pathogenesis of Parkinson's disease
-
S. Przedborski and M. Vila, The 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model: A tool to explore the pathogenesis of Parkinson's disease. Ann. N. Y. Acad. Sci. 991, 189 (2003).
-
(2003)
Ann. N. Y. Acad. Sci.
, vol.991
, pp. 189
-
-
Przedborski, S.1
Vila, M.2
-
36
-
-
70449527787
-
Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation
-
M. Moon, H. G. Kim, L. Hwang, J. H. Seo, S. Kim, S. Hwang, S. Kim, D. Lee, H. Chung, M. S. Oh, K. T. Lee, and S. Park, Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotox. Res. 15, 332 (2009).
-
(2009)
Neurotox. Res.
, vol.15
, pp. 332
-
-
Moon, M.1
Kim, H.G.2
Hwang, L.3
Seo, J.H.4
Kim, S.5
Hwang, S.6
Kim, S.7
Lee, D.8
Chung, H.9
Oh, M.S.10
Lee, K.T.11
Park, S.12
-
37
-
-
0031899172
-
Oxidative mechanisms in nigral cell death in Parkinson's disease
-
P. Jenner, Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 13, 24 (1998).
-
(1998)
Mov. Disord.
, vol.13
, pp. 24
-
-
Jenner, P.1
|